We examined the prevalence of elevated plasma high-sensitivity C-reactive protein (hs-CRP) concentrations and associations with red blood cell (RBC) long-chain n-3 polyunsaturated fatty acids (LCn-3PUFA) in the James Bay Cree population from the province of Quebec (Canada). SUBJECTS/METHODS: A total of 744 Cree adults (18-91 years) from seven communities of Eastern James Bay were included in these cross-sectional analyses. Associations between RBC LCn-3PUFA and proinflammatory markers (hs-CRP, interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α)) were assessed by using multivariate general linear models with adjustment for sex, age and waist circumference. An arbitrary inflammation score was defined based on the sum of the quartiles of hs-CRP, IL-6 and TNF-α concentrations (range = 3-12). RESULTS: Elevated hs-CRP concentrations (43 mg/l) were present in 46.9% (95% confidence interval (CI) 43.3-50.5) of the James Bay Cree population. RBC docosapentaenoic acid (DPAn-3; C22:5n-3) was inversely associated with hs-CRP, TNF-α and the inflammation score (all P trend o 0.02), whereas eicosapentaenoic acid (C20:5n-3) and docosahexaenoic acid (C22:6n-3) in RBC were not associated with inflammation (all P trend40.18). Among participants with RBC DPAn-3 levels above the median of the population, odds ratio of having an elevated inflammation score (⩾9) was 0.67 (95% CI, 0.48-0.93) compared with participants below the median. CONCLUSIONS: Results indicate that low-grade systemic inflammation is highly prevalent and that higher RBC DPAn-3 levels are associated with a lower risk of systemic inflammation in the James Bay Cree population.
INTRODUCTION
Detrimental impact of westernization of Canadian First Nations' diet and lifestyle on metabolic disorders such as obesity, type 2 diabetes and cardiovascular diseases is well known. [1] [2] [3] [4] [5] Cardiometabolic disorders are associated with a chronic low-grade inflammatory state, 6 often reflected by increased concentrations of proinflammatory mediators such as C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). Previous studies have shown that elevated CRP concentrations (43.0 mg/l) are present in 450% of First Nations adult communities from Ontario, Canada, with even higher values noted among women. 7, 8 Proinflammatory biomarker concentrations have also been positively associated with age, 7 plasma levels of persistent organic pollutants 9 and several features of the metabolic syndrome (MetS), including adiposity indices, fasting glucose and insulin 7, 10 in Oji-Cree communities from northwestern Ontario. However, the prevalence and correlates of elevated proinflammatory biomarker concentrations among the Cree communities of Eastern James Bay (Quebec, Canada) have not been described yet.
Cross-sectional studies conducted primarily in Caucasian populations have shown a consistent inverse association between fish consumption or the intake of long-chain n-3 polyunsaturated fatty acids (LCn-3PUFA) such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), estimated from dietary questionnaires or blood levels, and inflammatory biomarker concentrations. [11] [12] [13] [14] [15] [16] [17] [18] [19] To the best of our knowledge, studies having investigated these associations among Aboriginals so far have been limited to Inuit populations. 20, 21 Although blood levels of LCn-3PUFA have previously been associated with traditional risk factors for cardiovascular diseases among First Nations communities such as the Cree population, 22 the extent to which LCn-3PUFA are associated with systemic inflammation in these communities remains unknown. Plasma phospholipid levels of EPA+DHA among the James Bay Cree population (3.9%) fall between levels seen among Aboriginal circumpolar populations such as Nunavik Inuit (northern Quebec; 8.0%) and levels observed in non-Aboriginal Quebecers (1.8%). 23 Investigating associations between blood levels of LCn-3PUFA and inflammation in the James Bay Cree population therefore provides information on how LCn-3PUFA relate to inflammation in a population with a moderately elevated LCn-3PUFA status.
The first objective of this study was to determine the prevalence of elevated high-sensitivity (hs)-CRP concentrations among the James Bay Cree population from the province of Quebec, Canada. The second objective was to assess the association between red blood cell (RBC) LCn-3PUFA, used as a biological marker of LCn-3PUFA dietary intake, [24] [25] [26] and inflammatory biomarker concentrations.
SUBJECTS AND METHODS

Population and study design
Data collection for this cross-sectional study was carried out between summer 2005 and summer 2009 as part of the 'Nituuchischaayihtitaau Aschii Multi-Community Environment and Health Study in Iiyiyiu Aschii', a health survey conducted among 7 coastal and inland Cree communities from Eastern James Bay (Quebec, Canada). The method used for selecting participants has been described previously. 27 As shown in Figure 1 , the final study sample included 744 subjects for the analyses of hs-CRP and 743 subjects for the analyses of IL-6 and TNF-α.
The 
Clinical data
Participants' medical files were reviewed to determine the prevalence of type 2 diabetes and the use of anti-inflammatory, antihypertensive, antidiabetic and lipid-lowering medications over the 12-month period that preceded the beginning of the study.
Blood samples, as well as anthropometric and physiological measurements, were obtained during a 2.5-h clinical session conducted by a research nurse. Participants were asked to fast for at least 8 h before blood sample collection. Collected blood samples were temporarily frozen at either − 20°C or − 80°C. Aliquots of samples were also sent to the Centre Hospitalier Universitaire de Québec, in Québec City, where they were stored at ⩽ − 80°C. Body weight, waist circumference, body mass index (BMI), body fat percentage and blood pressure measurements were described previously. 27, 29 Elevated waist circumference was defined as ⩾ 90 cm in men and ⩾ 80 cm in women according to the International Diabetes Federation classification of central obesity for First Nations. 30 The presence of the MetS was determined using the International Diabetes Federation classification in First Nations. 30 RBC fatty acid determination. Individual LCn-3PUFA were quantified in RBC membrane phospholipids by gas-liquid chromatography and were expressed as the percentage of total fatty acids. Fatty acid determination has been previously described elsewhere. 27 Measurement of hs-CRP, IL-6 and TNF-α. Inflammatory biomarkers were analyzed in batches on samples stored at − 80°C. Plasma hs-CRP concentrations were measured by nephelometry, as previously described. 31 TNF-α and IL-6 were measured in EDTA-plasma using a human TNF-α and a human IL-6 ELISA kit (Quantikine HS, R&D System, Minneapolis, MN, USA), respectively. An arbitrary inflammation score was created to reflect an overall inflammatory profile. The score ranges from 3 to 12 points and corresponds to the sum of the individual quartiles of hs-CRP, IL-6 and TNF-α concentrations (Q1 = 1 point; Q2 = 2 points; Q3 = 3 points; Q4 = 4 points). Thus, the inflammation score is positively associated with low-grade systemic inflammation.
Other biochemical measurements. Analyses of total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triacylglycerol, fasting insulin, fasting glucose, toxic metals (that is, lead, mercury, cadmium), persistent organic pollutants and seroprevalence of zoonoses have been described previously. 27, 29, 32 Seroprevalence of zoonoses (positive or negative) was considered positive when an individual tested positive for at least one of the pathogens tested. Equivocal values were classified in the negative category.
Lifestyle and socioeconomic data An individual questionnaire administered by a local interviewer either in Iiyiyiuyimuwin or in English was used to collect information on gender, age and smoking habits. Physical activity was assessed using the short version of the International Physical Activity Questionnaire. 33 
Dietary intake
An 81-item interviewer-administered semiquantitative food frequency questionnaire inquiring on the consumption of traditional and commercial food items was used to estimate the daily frequency of consumption of fish and alcoholic beverages. Details on the food frequency questionnaire are provided in Supplementary File S1.
Statistical analyses
Elevated plasma hs-CRP concentrations were defined as 43.0 mg/l, as suggested by the American Heart Association. 34 An elevated inflammation score was defined as ⩾ 9 points, which is the equivalent of having a value above the median of the population for each of the three proinflammatory markers analyzed (hs-CRP, IL-6 and TNF-α).
Chi-square tests were used to compare the prevalence of elevated plasma hs-CRP concentrations between subgroups of individuals stratified on the basis of sex (men/women), age (18-39 years versus ⩾ 40 years), waist circumference (low/high) and MetS (yes/no).
Multivariate general linear models (SAS PROC GLM) were used to assess the association between quartiles of RBC EPA, DPAn-3 and DHA levels and inflammation. Covariates considered in the models were sex (male/female), age (continuous) and waist circumference (continuous). Adjusted means (95% confidence intervals (CIs)) were computed by quartiles of RBC LCn-3PUFA for each inflammatory marker. Adjusting for body weight, BMI or body fat instead of waist circumference led to similar results (data not shown). Further adjustments for RBC total n-6 and trans fatty acids, for environmental contaminants (persistent organic pollutants, including polychlorinated biphenyls and organochlorine pesticides), for toxic metals (cadmium, mercury, lead), for the presence of type 2 diabetes or for the use of anti-inflammatory, antihypertensive, antidiabetic or lipid-lowering medication also had no influence on the observed results (data not shown). These variables were therefore not retained in the final analyses of the data. Tests for trend across quartiles of RBC LCn-3PUFA were included in all models using the CONTRAST option 'linear'. Median scores in each quartile category were used for the trend analysis.
Eligible participants aged ≥ ≥ 15 years n=2240
Included participants: hs-CRP analyses, n=744 IL-6 and TNF-α analyses, n=743 Associations between RBC levels of individual LCn-3PUFA and the consumption of fish were assessed using the Spearman's correlation coefficients.
Multivariate logistic regression analysis was used to characterize the odds of having an elevated inflammation score according to demographic, anthropometric, biochemical, lifestyle and nutritional (that is, RBC LCn-3PUFA) variables. Odds ratio (OR) and 95% CI were calculated for each variable individually, using a multivariate model that included sex, age (continuous) and waist circumference (low/high) as covariates. The number of subjects in each model varied depending on the outcome of interest but was always ⩾ 719 participants after exclusion of missing covariates. Details on the number and percentage of missing data for each covariable are provided in Supplementary File S2. A single multivariate logistic model was used to determine which risk factors overall remained significant and independent predictors of a high inflammation score.
Continuous data are presented as means (95% CI) unless stated otherwise. Non-normally distributed variables were natural logtransformed before analysis. Thus geometric means (95% CI) are shown for these variables. Statistical analyses were performed using the SAS software (version 9.2; SAS Institute Inc., Cary, NC, USA). Statistical significance was set at a P-valueo0.05. Table 1 shows characteristics of the study participants by sex. Participants (55% women) had a mean age of 39.6 years (95% CI 38.5-40.8), a mean BMI of 33.2 kg/m 2 (95% CI 32.7-33.7) and half were occasional or daily smokers (52%; data not shown). Prevalence of utilization of lipid-lowering, antidiabetic, anti-inflammatory or antihypertensive medication ranged from 11% to 25%. Type 2 diabetes prevalence in men and women combined was 23%.
RESULTS
The prevalence of hs-CRP concentrations 43.0 mg/l was 46.9% (95% CI 43.3-50.5) and was higher among women (56.5%, 95% CI 51.6-61.3) than among men (35.1%, 95% CI 30.0-40.3, P o 0.0001). The prevalence of hs-CRP concentrations 43.0 mg/l was also higher among individuals with a high vs normal waist circumference (48.3% vs 18.0%, P = 0.0002) and among individuals with MetS vs no MetS (51.4% vs 41.3%, P = 0.006). The proportion of individuals with hs-CRP concentrations 43.0 mg/l did not differ according to age (18-39 years, 47.3% vs ⩾ 40 years, 46.4%, P = 0.79). Table 2 shows the age-, sex-and waist circumference-adjusted inflammatory biomarker concentrations across quartiles of RBC EPA, DPAn-3 and DHA. Hs-CRP, TNF-α and the inflammation score were lower across increasing quartiles of RBC DPAn-3 (all P trend o0.02), whereas IL-6 showed no statistical association with RBC DPAn-3 (P trend = 0.77). RBC EPA and DHA levels were not associated with any inflammatory biomarker (all P trend40.18). The correlation between fish consumption estimated by the food frequency questionnaire and RBC DPAn-3 was lower overall (r = 0.19, P o0.0001) than for EPA or DHA (r = 0.42 and r = 0.43, respectively, both P o 0.0001).
Risk factors for an elevated inflammation score in the James Bay Cree population were identified using a multivariate logistic model. Female sex (vs male, OR = 2.27, 95% CI 1.64-3.15) and high waist circumference (vs normal waist, OR = 3.16, 95% CI 1.20-8.31) increased the odds of having an elevated inflammation score in the James Bay Cree population. Insulin concentrations (log) (OR = 1.76, 95% CI 1.33-2.35) were also positively associated, whereas community of residence (inland vs coastal, OR = 0.43, 95% CI 0.30-0.62), HDL-C concentrations (OR = 0.39, 95% CI 0.22-0.68) and RBC DPAn-3 levels above the median of the population (vs levels below the median, OR = 0.67, 95% CI 0.48-0.92) were inversely associated with the odds of having an inflammation score ⩾ 9 (all P o 0.02). Each of these variables was considered individually, after adjustment for age, sex and waist circumference. The following variables showed no association with the inflammation score: LDL-C, triacylglycerol, fasting glucose, systolic blood pressure, diastolic blood pressure, physical activity, smoking status, drinking status, type 2 diabetes, environmental contaminants, toxic metals, the use of anti-inflammatory, antihypertensive, antidiabetic or lipid-lowering medication and RBC EPA and DHA. As shown in Table 3 , when considering all Abbreviations: BMI, body mass index; C, cholesterol; HDL, high-density lipoprotein; hs-CRP, high-sensitivity C-reactive protein; IL-6, interleukin 6; LDL, low-density lipoprotein; MET, metabolic equivalent of task; TNF-α, tumor necrosis factor-alpha. a n = 316-333 for men and n = 387-411 for women, depending on the variable. Values are arithmetic means (95% confidence intervals) for normally distributed variables and geometric means (95% confidence intervals) for non-normally distributed variables, unless stated otherwise. Score ranging from 3 to 12 points, corresponding to the sum of the quartiles in which individuals are present for hs-CRP, IL-6 and TNF-α concentrations (Q1 = 1 point; Q2 = 2 points; Q3 = 3 points; Q4 = 4 points). significant risk factors simultaneously in a single multivariate model, only sex, community of residence, HDL-C, insulin (log) and RBC DPAn-3 remained independently associated with the odds of having an elevated inflammation score (all P o0.03). The direction of the associations remained the same as described above.
DISCUSSION
To the best of our knowledge, this study is the first to determine the prevalence of elevated plasma hs-CRP concentrations in the James Bay Cree population from northern Quebec and to assess the associations between RBC LCn-3PUFA and inflammation in a Canadian First Nations community.
Our data suggest that almost half (≈47%) of the James Bay Cree population has elevated hs-CRP concentrations. This prevalence is almost twice that of Canadians of European origin (25.0%) 8 and more than twice that of the Inuit population from northern Quebec (21.4%). 35 On the other hand, this prevalence is comparable to the prevalence observed in First Nations communities from Ontario, Canada (54.8% in Anand et al. 8 or 51% for women and 32% for men, based on a cut-off of 3.8 mg/l in Connelly et al. ). Consistent with previous studies in First Nations 7, 8 and other Aboriginal communities such as the Inuit, 35 we showed that the prevalence of elevated hs-CRP concentrations is considerably higher among women than among men. Interestingly, in contrast to studies that support a positive association between age and low-grade systemic inflammation, 7, 36 we showed that the prevalence of elevated hs-CRP concentrations did not differ according to age in the James Bay Cree population. Other risk factors appear to outweigh the impact of age on inflammation in this population. Hs-CRP concentrations 43 mg/l have been associated with an increased risk of coronary heart disease in the general population, 34 but further investigations are warranted to determine how elevated hs-CRP concentrations relate to future coronary heart disease events in First Nations communities. Nevertheless, observations from our study and other Abbreviations: DHA, docosahexaenoic acid; DPA, docosapentaenoic acid; EPA, eicosapentaenoic acid; hs-CRP, high-sensitivity C-reactive protein; IL-6, interleukin 6; RBC, red blood cell; LCn-3PUFA, long-chain n-3 polyunsaturated fatty acids; TNF-α, tumor necrosis factor-alpha. a n = 729 for hs-CRP and n = 728 for IL-6, TNF-α and the inflammation score. Associations were assessed using the general linear model (GLM) procedure. Geometric means (95% confidence intervals) are shown for hs-CRP, IL-6 and TNF-α. Arithmetic means (95% confidence intervals) are shown for the inflammation score. Means are adjusted for age, sex and waist circumference.
b Values are expressed as percentage of total fatty acids in erythrocyte membrane phospholipids and represent the median percentage in each quartile. OR and 95% CI were determined using a multivariate logistic regression model in SAS, simultaneously taking into account all shown variables. ORs for each variable are thus adjusted for all other variables in the table.
b The inflammation score is a score ranging from 3 to 12 points, corresponding to the sum of the quartiles in which individuals are present for hs-CRP, IL-6 and TNF-α concentrations (Q1 = 1 point; Q2 = 2 points; Q3 = 3 points; Q4 = 4 points). An elevated inflammation score (⩾9) is the equivalent of having a value above the median of the population for each of the proinflammatory markers analyzed, that is, hs-CRP, IL-6 and TNF-α.
c High waist circumference cutoffs were ⩾ 90 cm in men and ⩾ 80 cm in women.
n-3 Fatty acids and inflammation among Cree M-È Labonté et al studies in First Nations communities highlight that systemic inflammation is a serious health concern that needs to be addressed in the context of the high prevalence of coronary heart disease in these populations.
So far, no study has documented the association between blood levels of LCn-3PUFA and inflammatory biomarkers in Canadian First Nations populations. Few studies conducted in other populations, [14] [15] [16] [17] [18] 20 but not all, 19, 37 have shown inverse associations between RBC, plasma and serum EPA and/or DHA and blood hs-CRP concentrations. Similar to our results, three out of five studies showed no association between IL-6 concentrations and plasma or RBC EPA and DHA, 17, 20, 37 whereas the other two studies showed inverse associations. 15, 19 Only two studies assessed TNF-α in addition to hs-CRP and IL-6 and showed no association with EPA and DHA measured in plasma. 17, 19 Makhoul et al. 20 have shown in a cohort of Yup'ik Eskimos, who consume very large amounts of EPA and DHA, that the inverse association between EPA and hs-CRP was stronger at values 43% of total fatty acids in erythrocytes. For DHA, a strong inverse association with hs-CRP was observed at DHA values 47% of total fatty acids, whereas the association appeared to be nonexisting below a value of 7%. In the present study, none of the participants had RBC EPA43% of total fatty acids, and only one participant had RBC DHA47% (not shown). This may explain the lack of association between RBC EPA and DHA and inflammatory biomarkers in the present study. Moreover, residual but very strong confounding effects of obesity may have masked associations between RBC EPA and DHA and low-grade systemic inflammation. Obesity indices, including waist circumference and BMI, were indeed higher across increasing quartiles of RBC EPA and DHA in the present study (all P trend ⩽ 0.0001, data not shown), whereas RBC DPAn-3 showed no such association with obesity indices.
Multivariate logistic regression analysis has shown that the association between RBC DPAn-3 and inflammation in the James Bay Cree population was independent of the community of residence (coastal vs inland), as well as of well-known correlates of inflammation among Aboriginal populations, such as female sex, HDL-C (inverse) and insulin. 8, 10, 38 The inverse association between RBC DPAn-3 and inflammation seen in the James Bay Cree population is consistent with the results from studies in other populations. 14, [16] [17] [18] 37 The absence of association between RBC DPAn-3 and IL-6 concentrations in the present study is also consistent with data from Sun et al. 37 In agreement with observations in the Finnish and US populations, 16, 18, 37 blood DPAn-3 in the present study was less strongly correlated with fish intake than EPA or DHA. This suggests that endogenous chain elongation from EPA may have a greater impact on blood DPAn-3 levels than direct dietary consumption. 39, 40 Although blood DPAn-3 appears as a poor marker for fish intake, 16 it is more strongly correlated with inflammation than EPA or DHA. 16, 17, 37 Little is known thus far on the mechanisms by which DPAn-3 may exert anti-inflammatory effects. DPAn-3 may reduce the expression of inflammatory genes or potentiate the production of DPA-related D-series resolvins and neuroprotectins, 40 which in turn may inhibit the production of inflammatory mediators as is the case with DHA-related pro-resolving molecules. 41 Nonetheless, intervention and experimental studies are warranted to confirm the antiinflammatory effects of DPAn-3 and to elucidate the underlying mechanisms for these effects.
The present study has a number of strengths and limitations that need to be pointed out. The use of validated objective biomarkers of dietary LCn-3PUFA intake [24] [25] [26] in a large number of subjects is a strength. Indeed, LCn-3PUFA estimates derived from dietary questionnaires are more prone to subjective measurement errors and bias. 42 However, owing to the cross-sectional design of the study, no causal relationship can be established. Although several factors known to influence proinflammatory processes such as environmental contaminants and medication use were taken into account in the analyses, we cannot exclude the possibility of residual confounding by unconsidered or unmeasured factors. The relatively low participation rate in the study (42%) may limit the representativeness of the sample to the whole James Bay Cree population. Nevertheless, our results regarding the prevalence of elevated hs-CRP concentrations among this population corroborate those observed among other Canadian First Nations.
In conclusion, elevated hs-CRP concentrations are highly prevalent among the James Bay Cree population, particularly among women and abdominally obese subjects. RBC DPAn-3, but not EPA or DHA, is inversely associated with inflammatory biomarkers in Cree adults even after adjustment for important covariates. Further longitudinal and interventional investigations are required to confirm this apparent anti-inflammatory effect of DPAn-3 seen in the James Bay Cree population.
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